Some Aspects of the Epidemiology of Migraine in Denmark

Dalsgaard‐Nielsen, T

doi:10.1111/j.1526-4610.1970.hed1001014.x

Cited by 42 publications

(22 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In children up to 7 years old, the prevalence of migraine has been reported to be ≤3 %. However, by 11 years old the prevalence of migraine increases to 11 %; and as children pass through adolescence (approximately 13–18 years old), the prevalence increases to 23 %–28 % [1, 22–27]. …”

Section: Epidemiology Of Primary Headachementioning

confidence: 99%

Headache and Obesity in the Pediatric Population

Oakley

Scher

Recober

et al. 2014

Curr Pain Headache Rep

View full text Add to dashboard Cite

Childhood obesity and headache are both significant health concerns that often have a marked impact both personally and socially, that if not addressed can carry over into adulthood. For many individuals, these effects may be magnified when obesity and headache are seen in conjunction. It is this overlap between obesity and headache in children, as well as similarities in the known mechanism of action for feeding and headache, which led to a suspected association between the two. Unfortunately, although recent studies have supported this association, only a limited number have been conducted to directly address this. Furthermore, despite rising rates of childhood obesity and headache, the associated medical comorbidities, and the significant financial cost for these conditions, there is a relative void in studies investigating treatment options that address both underlying conditions of obesity and headache in children.

show abstract

Section: Epidemiology Of Primary Headachementioning

confidence: 99%

Headache and Obesity in the Pediatric Population

Oakley

Scher

Recober

et al. 2014

Curr Pain Headache Rep

View full text Add to dashboard Cite

show abstract

“…Five selected articles published before 1980 that were found in bibliographies of recent publications also were included as they contained important epidemiologic data from large case series of children. 2,7,[10][11][12] The age qualifier of 3 to 18 years was selected, as this is the age group, based on previous literature, when most children are seen for pediatric or neurologic evaluation. Searches included titles from English and non-English language journals.…”

Section: Methodsmentioning

confidence: 99%

“…[7][8][9][10][11][12] Based on data from six retrospective case series between 1962 and 1994 of 13,130 children and adolescents, prevalence data for migraine headache by age groups were: 3 to 7 years old-1.2 to 3.2% (male [M] Ͼ female [F]); 7 to 11 years old-4 to 11% (M ϭ F); and 11 to Ն15 years old: 8 to 23% (F Ͼ M). [7][8][9][10][11][12] The evaluation of a child with headache begins with a thorough medical history followed by methodical physical examination with measurement of vital signs, particularly blood pressure, and a complete neurologic examination including examination of the optic fundus. Diagnosis of primary headache disorders of children rests principally on clinical criteria as set forth by the International Headache Society.…”

mentioning

confidence: 99%

Practice parameter: Evaluation of children and adolescents with recurrent headaches

Lewis

Ashwal²,

Dahl³

et al. 2002

Neurology

345

View full text Add to dashboard Cite

Abstract-Objective:The Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society develop practice parameters as strategies for patient management based on analysis of evidence. For this parameter, the authors reviewed available evidence on the evaluation of the child with recurrent headaches and made recommendations based on this evidence. Methods: Relevant literature was reviewed, abstracted, and classified. Recommendations were based on a four-tiered scheme of evidence classification. Results: There is inadequate documentation in the literature to support any recommendation as to the appropriateness of routine laboratory studies or performance of lumbar puncture. EEG is not recommended in the routine evaluation, as it is unlikely to define or determine an etiology or distinguish migraine from other types of headaches. In those children undergoing evaluation for recurrent headache found to have a paroxysmal EEG, the risk for future seizures is negligible; therefore, further investigation for epilepsy or treatments aimed at preventing future seizures is not indicated. Obtaining a neuroimaging study on a routine basis is not indicated in children with recurrent headaches and a normal neurologic examination. Neuroimaging should be considered in children with an abnormal neurologic examination or other physical findings that suggest CNS disease. Variables that predicted the presence of a space-occupying lesion included 1) headache of less than 1-month duration; 2) absence of family history of migraine; 3) abnormal neurologic findings on examination; 4) gait abnormalities; and 5) occurrence of seizures. Conclusions: Recurrent headaches occur commonly in children and are diagnosed on a clinical basis rather than by any testing. The routine use of any diagnostic studies is not indicated when the clinical history has no associated risk factors and the child's examination is normal.

show abstract

“…The prevalence data for migraine headache in childhood and adolescence range from 1.2% to 3.2% (male [M] greater than female [F]) in 3-7-year-old patients, up to 8-23% (F 4 M) in 11-to 415-year-old adolescents [Valquist, 1955;Dalsgaard-Nielsen, 1970;Small and Waters, 1974;Sillanpaa, 1976;Mortimer et al, 1992;Lipton et al, 1994]. The difference in migraine prevalence in various child series may reflect the specific quality of the studies, the migraine definition used, and the process of obtaining the history (e.g., questionnaire versus interview).…”

Section: Introductionmentioning

confidence: 99%

Evidence‐based medicine in migraine prophylactic treatment in childhood and adolescence

Balottin

Ferri

Termine

2007

Drug Development Research

View full text Add to dashboard Cite

Migraine is a common and disabling disorder, affecting children, adolescents, and adults. Prophylactic therapy should be considered when specific clinical conditions are fulfilled. Its goal is to reduce the frequency and duration of the attacks as well as the severity of pain, thus allowing patients to regain routine activities and ameliorating their quality of life. Using the principles of evidence-based medicine, a review of available published data on the efficacy and safety of prophylactic treatments for migraine in children and adolescents is presented. Currently, only flunarizine and psychologically based interventions (e.g., relaxation training, biofeedback, and psychotherapeutic techniques) may be effective in migraine prophylaxis in children and adolescents. Owing to the paucity of evidence, there is a need for large, controlled, randomized, and masked trials. Clinical researchers should consider that migraine, especially in childhood and adolescence, is a complex condition, resulting from the interaction between biological, psychological, and environmental factors. Specific events, constitutional predisposition, individual and environmental-emotional dynamics can play a significant role in the genesis and evolution of pain. Age-related characteristics such as prevalence, diagnosis, quality of life, and therapy should be considered designing future studies. Drug Dev Res 68: 461-468, 2007.

show abstract

Some Aspects of the Epidemiology of Migraine in Denmark

Cited by 42 publications

References 0 publications

Headache and Obesity in the Pediatric Population

Headache and Obesity in the Pediatric Population

Practice parameter: Evaluation of children and adolescents with recurrent headaches

Evidence‐based medicine in migraine prophylactic treatment in childhood and adolescence

Contact Info

Product

Resources

About